Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.4629
H.R.4629: Star Rating for Biosimilars Act
About This Bill
- This bill was introduced in the 116th Congress
- This bill is primarily about health
- Introduced Oct. 8, 2019
- Latest Major Action Oct. 18, 2019
- See the one similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsor
Bill Version
- Introduced in House - Oct. 8, 2019
Bill Summary
Star Rating for Biosimilars Act This bill requires the Centers for Medicare & Medicaid Services (CMS) to establish quality measures regarding biosimilar biological products under the five-star performance rating system for Medicare Advantage plans. The measures must assess the level of access that plans provide to covered biosimilars, including with respect to formularies, cost-sharing, and utilization management. The CMS must also...
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
| Date | Description |
|---|---|
| Oct. 9, 2019 |
Referred to the Subcommittee on Health.
|
| Oct. 8, 2019 |
Referred to the Subcommittee on Health.
|
| Oct. 8, 2019 |
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
| Oct. 8, 2019 |
Introduced in the House by Paul Tonko (D-N.Y.) |